{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:46:53Z","timestamp":1787244413633,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012765","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000}}],"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["97.03.160.40488"],"award-info":[{"award-number":["97.03.160.40488"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Cutaneous leishmaniasis (CL) is a tropical disease that can cause chronic lesions and leave life-long scars, leading to social stigmatization and psychological disorders. Using growth factors and immunomodulatory agents that could accelerate wound healing and reduce the scar is highly demanded. Epidermal growth factor (EGF) plays an essential role in wound healing. It stimulates the proliferation of keratocytes and fibroblasts, and promotes re-epithelialization. Here, the effect of EGF in combination with Glucantime and nano-liposomal Amphotericin B (SinaAmpholeish) on the healing process of CL in BALB\/c mice was investigated. Seventy-two mice were infected with\n                    <jats:italic>Leishmania major<\/jats:italic>\n                    parasites and randomly divided into eight treatment groups after the appearance of the lesion. The treatment was continued for five weeks, and lesion sizes were measured weekly. Parasite load was determined in the skin biopsies using qPCR. We found that subcutaneous injection of EGF at 4.5 \u03bcg\/kg, combined with each of the two antileishmanial drugs, significantly reduced the wound size and parasite load; however, EGF at 1.5 \u03bcg\/kg failed to be effective. Besides, the wound size and parasite loads were significantly lower in the SinaAmfoleish groups compared to the Glucantime groups. Among the treatment groups, EGF 4.5 \u03bcg\/kg combined with SinaAmpholeish exhibited the most significant reduction in wound size and parasitic load. Our results suggest that EGF can potentiate the wound healing effect of antileishmanial drugs. Further studies are warranted to explore the beneficial effects of combining EGF with antileishmanial drugs in patients with cutaneous leishmaniasis in order to accelerate wound healing and reduce the scar.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0012765","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:41:31Z","timestamp":1736862091000},"page":"e0012765","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB\/c mice"],"prefix":"10.1371","volume":"19","author":[{"given":"Mohammad","family":"Saberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Latifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Golkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pezhman","family":"Fard-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Mohtasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Teimouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Abbaszadeh Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Kazemirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-9514","authenticated-orcid":true,"given":"Mehdi","family":"Mohebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"pntd.0012765.ref001","article-title":"World Health Organization Leishmaniasis factsheet","author":"WHO"},{"issue":"98","key":"pntd.0012765.ref002","first-page":"471","article-title":"Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years.","volume":"40","author":"JS Ruiz-Postigo JA","year":"2023","journal-title":"Weekly Epidemiological Record = Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"issue":"2","key":"pntd.0012765.ref003","doi-asserted-by":"crossref","first-page":"e0007996","DOI":"10.1371\/journal.pntd.0007996","article-title":"Patients\u2019 preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study.","volume":"14","author":"AC Erber","year":"2020","journal-title":"PLoS neglected tropical diseases."},{"key":"pntd.0012765.ref004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpubh.2020.00011","article-title":"The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review.","volume":"8","author":"MA Ghatee","year":"2020","journal-title":"Frontiers in public health"},{"key":"pntd.0012765.ref005","doi-asserted-by":"crossref","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: Recent epidemiological studies in the Middle East.","volume":"13","author":"CA Knight","year":"2022","journal-title":"Frontiers in microbiology"},{"issue":"1","key":"pntd.0012765.ref006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40249-023-01103-1","article-title":"High-risk spatiotemporal patterns of cutaneous leishmaniasis: a nationwide study in Iran from 2011 to 2020.","volume":"12","author":"N Firouraghi","year":"2023","journal-title":"Infectious diseases of poverty."},{"issue":"2","key":"pntd.0012765.ref007","doi-asserted-by":"crossref","first-page":"e0009181","DOI":"10.1371\/journal.pntd.0009181","article-title":"The global procurement landscape of leishmaniasis medicines.","volume":"15","author":"HL Choi","year":"2021","journal-title":"PLoS neglected tropical diseases."},{"key":"pntd.0012765.ref008","doi-asserted-by":"crossref","first-page":"102863","DOI":"10.1016\/j.parint.2024.102863","article-title":"A review on potential therapeutic targets for the treatment of leishmaniasis","volume":"100","author":"SY Sheikh","year":"2024","journal-title":"Parasitology international"},{"issue":"1","key":"pntd.0012765.ref009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00403-018-1872-2","article-title":"Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport","volume":"311","author":"M Mohebali","year":"2019","journal-title":"Archives of Dermatological Research"},{"issue":"3","key":"pntd.0012765.ref010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/mmy\/myv111","article-title":"Comparison between liposomal formulations of amphotericin B","volume":"54","author":"JP Adler-Moore","year":"2016","journal-title":"Medical mycology"},{"issue":"2","key":"pntd.0012765.ref011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpddr.2018.04.001","article-title":"Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis","volume":"8","author":"GJ Wijnant","year":"2018","journal-title":"International journal for parasitology Drugs and drug resistance"},{"issue":"9","key":"pntd.0012765.ref012","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02525-16","article-title":"Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B","volume":"61","author":"M Iman","year":"2017","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"pntd.0012765.ref013","first-page":"197","article-title":"Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial.","volume":"14","author":"SE Eskandari","year":"2019","journal-title":"Iranian journal of parasitology"},{"issue":"9","key":"pntd.0012765.ref014","doi-asserted-by":"crossref","first-page":"658","DOI":"10.26719\/emhj.22.070","article-title":"Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran","volume":"28","author":"A Khamesipour","year":"2022","journal-title":"Eastern Mediterranean health journal"},{"issue":"4","key":"pntd.0012765.ref015","first-page":"419","article-title":"Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish) Alone or in Combination with Glucantime and Cryotherapy on Human Cutaneous Leishmaniasis.","volume":"18","author":"Z Alizadeh","year":"2023","journal-title":"Iranian journal of parasitology"},{"key":"pntd.0012765.ref016","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","article-title":"Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro","volume":"139","author":"AP Perez","year":"2016","journal-title":"Colloids and surfaces B, Biointerfaces"},{"key":"pntd.0012765.ref017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpddr.2019.09.004","article-title":"Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis","volume":"11","author":"MR Jaafari","year":"2019","journal-title":"International journal for parasitology Drugs and drug resistance"},{"issue":"2","key":"pntd.0012765.ref018","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review.","volume":"11","author":"RK Madusanka","year":"2022","journal-title":"Infectious diseases and therapy."},{"key":"pntd.0012765.ref019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cimid.2017.02.001","article-title":"Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-\u03b2","volume":"51","author":"A Abdoli","year":"2017","journal-title":"Comparative immunology, microbiology and infectious diseases"},{"issue":"6","key":"pntd.0012765.ref020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12262-012-0447-2","article-title":"Role of epidermal growth factor in healing of diabetic foot ulcers","volume":"74","author":"S Singla","year":"2012","journal-title":"The Indian journal of surgery"},{"issue":"3","key":"pntd.0012765.ref021","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4049\/jimmunol.1301062","article-title":"EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis","volume":"192","author":"Z Zhang","year":"2014","journal-title":"Journal of immunology (Baltimore, Md: 1950)."},{"issue":"5","key":"pntd.0012765.ref022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/17469872.3.5.525","article-title":"Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin","volume":"3","author":"S Pastore","year":"2008","journal-title":"Expert review of dermatology"},{"key":"pntd.0012765.ref023","first-page":"9439182","article-title":"Epidermal Growth Factor Relieves Inflammatory Signals in Staphylococcus aureus-Treated Human Epidermal Keratinocytes and Atopic Dermatitis-Like Skin Lesions in Nc\/Nga Mice.","volume":"2018","author":"SY Choi","year":"2018","journal-title":"BioMed research international."},{"issue":"33","key":"pntd.0012765.ref024","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1016\/j.biomaterials.2012.07.061","article-title":"The effect of epidermal growth factor (EGF) conjugated with low-molecular-weight protamine (LMWP) on wound healing of the skin.","volume":"33","author":"JK Choi","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"pntd.0012765.ref025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1742-481X.2008.00561.x","article-title":"Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.","volume":"6","author":"JI Fern\u00e1ndez-Montequ\u00edn","year":"2009","journal-title":"Int Wound J"},{"issue":"4","key":"pntd.0012765.ref026","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3346\/jkms.2010.25.4.589","article-title":"Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing","volume":"25","author":"YS Kim","year":"2010","journal-title":"Journal of Korean medical science"},{"key":"pntd.0012765.ref027","article-title":"The use of epidermal growth factor in dermatological practice","author":"SH Shin","year":"2022","journal-title":"International wound journal"},{"issue":"8","key":"pntd.0012765.ref028","article-title":"Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration.","volume":"22","author":"JW Park","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"key":"pntd.0012765.ref029","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fcimb.2018.00350","article-title":"Transforming Growth Factor Beta (TGF\u03b21) and Epidermal Growth Factor (EGF) as Biomarkers of Leishmania (V) braziliensis Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in Hamsters.","volume":"8","author":"A Montoya","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"pntd.0012765.ref030","doi-asserted-by":"crossref","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","article-title":"Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"N Percie du Sert","year":"2020","journal-title":"PLOS Biology"},{"issue":"11","key":"pntd.0012765.ref031","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"D Sacks","year":"2002","journal-title":"Nature reviews Immunology"},{"issue":"6","key":"pntd.0012765.ref032","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1269\/jrr.09066","article-title":"Recombinant human epidermal growth factor accelerates the proliferation of irradiated human fibroblasts and keratinocytes in vitro and in vivo","volume":"50","author":"SH Ryu","year":"2009","journal-title":"Journal of radiation research"},{"key":"pntd.0012765.ref033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.08.002","article-title":"The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.","volume":"10","author":"LF Gon\u00e7alves-Oliveira","year":"2019","journal-title":"International journal for parasitology Drugs and drug resistance"},{"issue":"12","key":"pntd.0012765.ref034","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1128\/IAI.68.12.6561-6566.2000","article-title":"Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice","volume":"68","author":"L Nicolas","year":"2000","journal-title":"Infection and immunity"},{"issue":"16","key":"pntd.0012765.ref035","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1007\/s00253-016-7422-y","article-title":"Solid lipid nanoparticle loaded with Paromomycin: in vivo efficacy against Leishmania tropica infection in BALB\/c mice model","volume":"100","author":"M Heidari-Kharaji","year":"2016","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"2","key":"pntd.0012765.ref036","doi-asserted-by":"crossref","first-page":"e0281622","DOI":"10.1371\/journal.pone.0281622","article-title":"Detection of Enterobius vermicularis in archived formalin-fixed paraffin-embedded (FFPE) appendectomy blocks: It\u2019s potential to compare genetic variations based on mitochondrial DNA (cox1) gene.","volume":"18","author":"M Haghshenas","year":"2023","journal-title":"PloS one."},{"issue":"3","key":"pntd.0012765.ref037","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijwd.2019.01.002","article-title":"Cutaneous leishmaniasis: A neglected disfiguring disease for women.","volume":"5","author":"A Bilgic-Temel","year":"2019","journal-title":"International journal of women\u2019s dermatology"},{"key":"pntd.0012765.ref038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41038-019-0148-1","article-title":"Advances in surgical applications of growth factors for wound healing","volume":"7","author":"S Yamakawa","year":"2019","journal-title":"Burns & trauma"},{"issue":"4","key":"pntd.0012765.ref039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12272-023-01444-3","article-title":"EGF, a veteran of wound healing: highlights on its mode of action, clinical applications with focus on wound treatment, and recent drug delivery strategies","volume":"46","author":"K Shakhakarmi","year":"2023","journal-title":"Archives of pharmacal research"},{"issue":"7","key":"pntd.0012765.ref040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00403-007-0765-6","article-title":"T helper type 1 cytokines and keratinocyte growth factor play a critical role in pseudoepitheliomatous hyperplasia initiation during cutaneous leishmaniasis","volume":"299","author":"OE Akilov","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"pntd.0012765.ref041","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13287-020-01889-z","article-title":"Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis","volume":"11","author":"TD Ramos","year":"2020","journal-title":"Stem cell research & therapy"},{"issue":"8","key":"pntd.0012765.ref042","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1590\/0074-02760160183","article-title":"Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre","volume":"111","author":"RE Silva","year":"2016","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"4\u20135","key":"pntd.0012765.ref043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2008.05.002","article-title":"Liposomes and skin: from drug delivery to model membranes. European journal of pharmaceutical sciences: official journal of the","volume":"34","author":"GM El Maghraby","year":"2008","journal-title":"European Federation for Pharmaceutical Sciences"},{"issue":"3","key":"pntd.0012765.ref044","first-page":"119","article-title":"Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB\/c mice.","volume":"65","author":"R Jabini","year":"2015","journal-title":"Drug research."},{"key":"pntd.0012765.ref045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","article-title":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial","volume":"142","author":"KH Park","year":"2018","journal-title":"Diabetes research and clinical practice"},{"key":"pntd.0012765.ref046","doi-asserted-by":"crossref","first-page":"773","DOI":"10.12688\/f1000research.121712.1","article-title":"Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis.","volume":"11","author":"F Rahim","year":"2022","journal-title":"F1000Research.PubMed Central PMCID"},{"issue":"1","key":"pntd.0012765.ref047","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13104-023-06470-4","article-title":"Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment.","volume":"16","author":"E Shadmand","year":"2023","journal-title":"BMC research notes"},{"issue":"10","key":"pntd.0012765.ref048","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"JB Santos","year":"2004","journal-title":"The Journal of infectious diseases"},{"key":"pntd.0012765.ref049","doi-asserted-by":"crossref","first-page":"627098","DOI":"10.3389\/fphar.2021.627098","article-title":"Therapeutic Effect of Epidermal Growth Factor Combined With Nano Silver Dressing on Diabetic Foot Patients.","volume":"12","author":"K Zhang","year":"2021","journal-title":"Frontiers in pharmacology"},{"key":"pntd.0012765.ref050","doi-asserted-by":"crossref","first-page":"111385","DOI":"10.1016\/j.msec.2020.111385","article-title":"Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic wound healing","volume":"118","author":"YH Lee","year":"2021","journal-title":"Materials science & engineering C, Materials for biological applications."},{"issue":"3","key":"pntd.0012765.ref051","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.burns.2019.12.015","article-title":"Efficacy and safety of nano-silver dressings combined with recombinant human epidermal growth factor for deep second-degree burns: A meta-analysis.","volume":"47","author":"S Li","year":"2021","journal-title":"Burns: journal of the International Society for Burn Injuries"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012765","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T13:54:49Z","timestamp":1737986089000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012765"}},"subtitle":[],"editor":[{"given":"Abhay R.","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012765","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}